QPW
TSHA icon

Quantum Private Wealth’s Taysha Gene Therapies TSHA Stock Holding History

Quantum Private Wealth’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.53M Sell
812,027
-37,185
-4% -$220K 1.42% 16
2026
Q1 		$3.8M Buy
849,212
+29,497
+4% +$137K 1.17% 15
2025
Q4 		$4.51M Sell
819,715
-2,361
-0.3% -$11.5K 1.32% 13
2025
Q3 		$2.69M Buy
822,076
+6,100
+0.7% +$17.3K 0.79% 25
2025
Q2 		$1.88M Buy
815,976
+24,500
+3% +$53.2K 0.61% 32
2025
Q1 		$1.1M Sell
791,476
-3,500
-0.4% -$5.85K 0.42% 49
2024
Q4 		$1.38M Buy
794,976
+27,360
+4% +$56.8K 0.44% 42
2024
Q3 		$1.54M Buy
767,616
+37,096
+5% +$81.4K 0.52% 38
2024
Q2 		$1.64M Buy
730,520
+32,000
+5% +$93.1K 0.58% 34
2024
Q1 		$2M Buy
698,520
+59,000
+9% +$123K 0.74% 25
2023
Q4 		$1.13M Buy
639,520
+64,140
+11% +$128K 0.47% 50
2023
Q3 		$1.82M Buy
575,380
+71,000
+14% +$133K 0.87% 22
2023
Q2 		$333K Buy
504,380
+145,013
+40% +$105K 0.15% 132
2023
Q1 		$287K Buy
359,367
+45,910
+15% +$59.3K 0.16% 138
2022
Q4 		$708K Buy
313,457
+84,388
+37% +$171K 0.45% 58
2022
Q3 		$442K Buy
229,069
+71,295
+45% +$259K 0.28% 93
2022
Q2 		$586K Buy
157,774
+5,800
+4% +$23K 0.35% 65
2022
Q1 		$990K Buy
151,974
+6,256
+4% +$46.8K 0.43% 46
2021
Q4 		$1.7M Buy
+145,718
New +$2.2M 0.64% 30

Other funds holding TSHA

Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vestal Point Capital
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Quantum Private Wealth's TSHA Position: Q2 2026 in Review

Quantum Private Wealth reduced its Taysha Gene Therapies (TSHA) stake by 4.4% in Q2 2026, selling an estimated $220K and leaving 812,027 shares worth $5.53M. The position accounts for 1.42% of the portfolio, ranked #16.

Quantum Private Wealth first reported a position in TSHA in Q4 2021 and has held it in 19 quarters since. 208 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • Quantum Private Wealth held 812,027 shares of Taysha Gene Therapies worth $5.53M as of Q2 2026.
  • Quantum Private Wealth sold 37,185 Taysha Gene Therapies shares in Q2 2026, an estimated $220K.
  • Taysha Gene Therapies made up 1.42% of Quantum Private Wealth's portfolio in Q2 2026, its #16 holding.
  • Quantum Private Wealth first reported a position in Taysha Gene Therapies in Q4 2021 and has held it in 19 quarters since.
  • 208 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on Quantum Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.